Farkas S - Search Results

1

Modeling long-term diabetes and related complications in rats.

Hajna Z, Szabadfi K, Balla Z, Biró Z, Degrell P, Molnár GA, Kőszegi T, Tékus V, Helyes Z, Dobos A, Farkas S, Szűcs G, Gábriel R, Pintér E. Hajna Z, et al. Among authors: farkas s. J Pharmacol Toxicol Methods. 2016 Mar-Apr;78:1-12. doi: 10.1016/j.vascn.2015.11.003. Epub 2015 Nov 14. J Pharmacol Toxicol Methods. 2016. PMID: 26589430

2

Utility of different outcome measures for the nitroglycerin model of migraine in mice.

Farkas S, Bölcskei K, Markovics A, Varga A, Kis-Varga Á, Kormos V, Gaszner B, Horváth C, Tuka B, Tajti J, Helyes Z. Farkas S, et al. J Pharmacol Toxicol Methods. 2016 Jan-Feb;77:33-44. doi: 10.1016/j.vascn.2015.09.006. Epub 2015 Oct 9. J Pharmacol Toxicol Methods. 2016. PMID: 26456070 Free article.

3

Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs.

Farkas S, Berzsenyi P, Kárpáti E, Kocsis P, Tarnawa I. Farkas S, et al. J Pharmacol Toxicol Methods. 2005 Sep-Oct;52(2):264-73. doi: 10.1016/j.vascn.2004.11.005. Epub 2005 Jan 12. J Pharmacol Toxicol Methods. 2005. PMID: 16125625

4

Predictive validity of endpoints used in electrophysiological modelling of migraine in the trigeminovascular system.

Farkas B, Kardos P, Orosz S, Tarnawa I, Csekő C, Lévay G, Farkas S, Lendvai B, Kovács P. Farkas B, et al. Among authors: farkas s. Brain Res. 2015 Nov 2;1625:287-300. doi: 10.1016/j.brainres.2015.08.039. Epub 2015 Sep 7. Brain Res. 2015. PMID: 26358146

5

The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR Rats.

Deres L, Eros K, Horvath O, Bencze N, Cseko C, Farkas S, Habon T, Toth K, Halmosi R. Deres L, et al. Among authors: farkas s. Front Physiol. 2019 May 21;10:624. doi: 10.3389/fphys.2019.00624. eCollection 2019. Front Physiol. 2019. PMID: 31178756 Free PMC article.

6

Receptor components of glutamate-evoked increase in intracellular Ca2+ concentration of neurons in culture.

Horváth C, Farkas S, Nagy J. Horváth C, et al. Among authors: farkas s. Neurobiology (Bp). 1999;7(1):69-70. Neurobiology (Bp). 1999. PMID: 10746251 No abstract available.

7

NR2B subunit selective NMDA antagonists inhibit neurotoxic effect of alcohol-withdrawal in primary cultures of rat cortical neurones.

Nagy J, Horváth C, Farkas S, Kolok S, Szombathelyi Z. Nagy J, et al. Among authors: farkas s. Neurochem Int. 2004 Jan;44(1):17-23. doi: 10.1016/s0197-0186(03)00100-1. Neurochem Int. 2004. PMID: 12963084

8

Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists.

Borza I, Kolok S, Galgóczy K, Gere A, Horváth C, Farkas S, Greiner I, Domány G. Borza I, et al. Among authors: farkas s. Bioorg Med Chem Lett. 2007 Jan 15;17(2):406-9. doi: 10.1016/j.bmcl.2006.10.033. Epub 2006 Oct 17. Bioorg Med Chem Lett. 2007. PMID: 17074483

9

Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists.

Borza I, Kolok S, Ignácz-Szendrei G, Greiner I, Tárkányi G, Galgóczy K, Horváth C, Farkas S, Domány G. Borza I, et al. Among authors: farkas s. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5439-41. doi: 10.1016/j.bmcl.2005.08.110. Epub 2005 Oct 5. Bioorg Med Chem Lett. 2005. PMID: 16213709

10

Oxamides as novel NR2B selective NMDA receptor antagonists.

Barta-Szalai G, Borza I, Bozó E, Kiss C, Agai B, Proszenyák A, Keseru GM, Gere A, Kolok S, Galgóczy K, Horváth C, Farkas S, Domány G. Barta-Szalai G, et al. Among authors: farkas s. Bioorg Med Chem Lett. 2004 Aug 2;14(15):3953-6. doi: 10.1016/j.bmcl.2004.05.053. Bioorg Med Chem Lett. 2004. PMID: 15225705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page